Cargando…

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome

OBJECTIVES: ST2 is a receptor for interleukin (IL)-33. We investigated an association of soluble ST2 (sST2) and IL-33 serum levels with different clinical stages of coronary artery disease. We assessed the predictive value of sST2 and IL-33 in patients with stable angina, non-ST elevation myocardial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demyanets, Svitlana, Speidl, Walter S., Tentzeris, Ioannis, Jarai, Rudolf, Katsaros, Katharina M., Farhan, Serdar, Krychtiuk, Konstantin A., Wonnerth, Anna, Weiss, Thomas W., Huber, Kurt, Wojta, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994012/ https://www.ncbi.nlm.nih.gov/pubmed/24751794 http://dx.doi.org/10.1371/journal.pone.0095055

Ejemplares similares

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
por: Katsaros, Katharina M., et al.
Publicado: (2015)

Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
por: Pentz, Richard, et al.
Publicado: (2018)

The Paradigm Change of IL-33 in Vascular Biology
por: Demyanets, Svitlana, et al.
Publicado: (2021)

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2014)

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
por: Stojkovic, Stefan, et al.
Publicado: (2016)

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro
por: Kastl, Stefan P., et al.
Publicado: (2020)

Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β
por: Jarai, Rudolf, et al.
Publicado: (2009)

Soluble neprilysin and survival in critically ill patients
por: Lenz, Max, et al.
Publicado: (2022)

Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)
por: Krychtiuk, Konstantin A., et al.
Publicado: (2015)

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
por: Rohla, Miklos, et al.
Publicado: (2016)

Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017)

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome
por: Stojkovic, Stefan, et al.
Publicado: (2023)

Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease—A 10-Year Cohort Study
por: Urban, Matthias H., et al.
Publicado: (2021)

Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study
por: Roth, Christian, et al.
Publicado: (2020)

Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
por: Klopf, Johannes, et al.
Publicado: (2022)

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Monocyte subsets predict mortality after cardiac arrest
por: Krychtiuk, Konstantin A., et al.
Publicado: (2020)

GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST2
por: Stojkovic, Stefan, et al.
Publicado: (2018)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
por: Lenz, Max, et al.
Publicado: (2021)

Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction
por: Lenz, Max, et al.
Publicado: (2023)

Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles
por: Hohensinner, Philipp J., et al.
Publicado: (2020)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic: A review
por: Burger, Achim Leo, et al.
Publicado: (2021)

Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
por: Farhan, Serdar, et al.
Publicado: (2016)

Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
por: Kim, Dae-Jun, et al.
Publicado: (2013)

Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans
por: Thaler, B., et al.
Publicado: (2016)

Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19
por: Kaufmann, Christoph C., et al.
Publicado: (2023)

Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery
por: Rega-Kaun, Gersina, et al.
Publicado: (2019)

Pharmacologic modulation of intracellular Na(+) concentration with ranolazine impacts inflammatory response in humans and mice
por: Lenz, Max, et al.
Publicado: (2022)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Interleukin‐4 receptor alpha signaling regulates monocyte homeostasis
por: Haider, Patrick, et al.
Publicado: (2022)

Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study
por: Farhan, Serdar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9q4gct253c358hjpg42o3ivvkc